Key result
TEER with embolic protection reduces severe mitral regurgitation to mild with zero recurrent strokes.
Why the study?
Non-bacterial thrombotic endocarditis often causes cerebrovascular embolism and is thought to be a contraindication to TEER in degenerative mitral regurgitation.
Does transcatheter edge-to-edge repair combined with bilateral carotid embolic protection prevent recurrent cerebral infarction and ameliorate severe mitral regurgitation in a high-risk patient with degenerative mitral regurgitation and concurrent nonbacterial thrombotic endocarditis?
Case Report (n=1)
No
Does transcatheter edge-to-edge repair combined with bilateral carotid embolic protection prevent recurrent cerebral infarction and ameliorate severe mitral regurgitation in a high-risk patient with degenerative mitral regurgitation and concurrent nonbacterial thrombotic endocarditis?
This case report demonstrates that transcatheter edge-to-edge repair paired with bilateral carotid embolic protection is feasible and can effectively reduce severe mitral regurgitation and prevent recurrent stroke in a high-risk patient with concurrent nonbacterial thrombotic endocarditis, a traditional contraindication to the procedure.
Answers are grounded in this paper and cite their sources.
May enable TEER with embolic protection in select NBTE cases; challenges contraindication status but leaves open broader validation.
BACKGROUND: Degenerative mitral regurgitation is a common valvular heart disease, with transcatheter edge-to-edge repair an alternative option for high-risk patients. Nonbacterial thrombotic endocarditis, a rare condition with sterile valvular excrescences, often causes cerebrovascular embolism and is thought to be the contraindication to transcatheter edge-to-edge repair. CASE SUMMARY: A 52-year-old man with multiple comorbidities presented to the hospital with recurrent cerebral infarctions, massive mitral regurgitation and nonbacterial thrombotic endocarditis. Transcatheter edge-to-edge repair and carotid embolic protection device implantation were performed to ameliorate mitral regurgitation, avoid the recurrence of cerebral embolism and delay the time for surgical valve replacement. DISCUSSION: The patient's history of antineutrophil cytoplasmic antibody-associated vasculitis, nephritis, and glucocorticoid use made surgical treatment risky. Transcatheter edge-to-edge repair is feasible for severe degenerative mitral regurgitation with nonbacterial thrombotic endocarditis, especially with carotid protection, which reduces embolism risk and postpones valve replacement. TAKE-HOME MESSAGE: This case demonstrates the feasibility of transcatheter edge-to-edge repair with concurrent nonbacterial thrombotic endocarditis and recurrent cerebral infarction when paired with carotid embolic protection.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) conducted a case report in Degenerative mitral regurgitation with nonbacterial thrombotic endocarditis and recurrent cerebral infarction (n=1). Transcatheter edge-to-edge repair (DragonFly XW0612 clip) with bilateral carotid embolic protection device implantation (Proender device) was evaluated on Recurrent cerebral infarction and mitral regurgitation severity at 6 months. Transcatheter edge-to-edge repair with bilateral carotid embolic protection reduced 4+ mitral regurgitation to mild (gradient 3 mm Hg) with 0 recurrent cerebral infarctions over 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: